SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-006521
Filing Date
2017-04-14
Accepted
2017-04-14 09:00:27
Documents
6
Period of Report
2017-05-25
Effectiveness Date
2017-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A dmtx-def14a_20170525.htm DEF 14A 719953
2 GRAPHIC g201704131714213922367.jpg GRAPHIC 139674
3 GRAPHIC g201704131714184982365.jpg GRAPHIC 6489
4 GRAPHIC g201704131714185712366.jpg GRAPHIC 6489
5 GRAPHIC g201704131714183182364.jpg GRAPHIC 6363
6 GRAPHIC g201704131714183082363.jpg GRAPHIC 6946
  Complete submission text file 0001564590-17-006521.txt   950404
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37601 | Film No.: 17762215
SIC: 2836 Biological Products, (No Diagnostic Substances)